首页 | 本学科首页   官方微博 | 高级检索  
检索        

黄芪甲苷联合依那普利治疗改善小鼠急性心肌梗死后心功能
引用本文:孙东岳,卢飞艳,丁燕子,吴恒芳,卞智萍,陈相健,杨 笛.黄芪甲苷联合依那普利治疗改善小鼠急性心肌梗死后心功能[J].南京医科大学学报,2018(7):945-949,1000.
作者姓名:孙东岳  卢飞艳  丁燕子  吴恒芳  卞智萍  陈相健  杨 笛
作者单位:南京医科大学第一附属医院心脏科,江苏 南京 210029,南京医科大学第一附属医院心脏科,江苏 南京 210029,南京医科大学第一附属医院心脏科,江苏 南京 210029,南京医科大学第一附属医院心脏科,江苏 南京 210029,南京医科大学第一附属医院心脏科,江苏 南京 210029,南京医科大学第一附属医院心脏科,江苏 南京 210029,南京医科大学第一附属医院心脏科,江苏 南京 210029
基金项目:科技部国家重点研发计划(2016YFA0201304);江苏省自然科学基金(BK20151587)
摘    要:目的:探讨黄芪甲苷(astragaloside IV,AS?IV)联合依那普利治疗急性心肌梗死小鼠对心功能改善及其促血管新生的作用机制。方法:24只8周龄雄性C57BL/6小鼠随机分为4组:假手术(Sham)组、对照(CTL)组、依那普利(Enalapril)组、黄芪甲苷+依那普利(AS?IV+Enalapril)组,除Sham组外,对CTL组、Enalapril组、AS?IV+Enalapril组3组小鼠均行冠状动脉左前降支结扎术构建心梗模型。对Enalapril组(Enalapril 7.5 mg/kg)、AS?IV+Enalapril组(AS+IV 10 mg/kg + Enalapril 7.5 mg/kg)小鼠分别以对应药物进行治疗。2周后行超声检查测定心功能。以HE染色观察心脏病理改变。以CD31/VEGFR3免疫荧光染色观察各组血管密度及血管新生情况。结果:与CTL组相比,Enalapril组和AS?IV+Enalapril组小鼠心功能得到明显改善,且AS?IV+Enalapril组优于Enalapril组;CD31/VEGFR3双荧光染色显示,与CTL组相比,Enalapril组和AS?IV+Enalapril组小鼠梗死边缘区血管密度增高,新生血管比率增高,且AS?IV+Enalapril组优于Enalapril组。结论:黄芪甲苷联合依那普利可有效改善急性心肌梗死后小鼠的心功能,并可促进心肌梗死边缘区血管新生。

关 键 词:黄芪甲苷  依那普利  小鼠  急性心肌梗死
收稿时间:2018/3/15 0:00:00
修稿时间:2018/5/25 0:00:00

Astragaloside-IV combined with Enalapril improves the cardiac function of mice with acute myocardial infarction
Sun Dongyue,Lu Feiyan,Ding Yanzi,Wu Hengfang,Bian Zhiping,Cheng Xiangjian and Yang Di.Astragaloside-IV combined with Enalapril improves the cardiac function of mice with acute myocardial infarction[J].Acta Universitatis Medicinalis Nanjing,2018(7):945-949,1000.
Authors:Sun Dongyue  Lu Feiyan  Ding Yanzi  Wu Hengfang  Bian Zhiping  Cheng Xiangjian and Yang Di
Institution:Department of Cardiology,the First Affiliated Hospital of Nanjing Medical University,,,,,,Department of Cardiology,the First Affiliated Hospital of Nanjing Medical University
Abstract:Objective: To investigate the effect of Astragaloside IV combined with Enalapril on cardiac function after acute myocardial infarction (AMI) in mice. Methods: Twenty-four 8-week old male C57BL/6 mice were randomly divided into 4 groups: (1) Sham group, (2) CTL group, (3) Enalapril group and (4) AS-IV+Enalapril group. CTL group, Enalapril group and AS-IV+Enalapril group were subjected to left anterior descending coronary artery ligation as AMI model. Mice in Enalapril group(Enalapril 7.5 mg/kg) and AS-IV+Enalapril group ( AS+IV 10 mg/kg + Enalapril 7.5 mg/kg) were treated with the corresponding medicine, respectively. Echocardiography was applied to measure cardiac function 2 weeks later. Pathological changes of heart were studied by HE staining. CD31/ VEGFR3 double immunofluorescent staining were used to observe the density of vessels and angiogenesis. Results: Compared to CTL group, the cardiac function was significantly improved in Enalapril group and AS-IV+Enalapril group, especially the latter one. Compared to CTL group, there was significantly more angiogenesis to be observed in the peri- infarction region of Enalapril group and AS-IV+Enalapril group, this effect was better in AS-IV+Enalapril group. Conclusion: Astragaloside-IV combined with Enalapril can effectively improve the cardiac function of mice after myocardial infarction and promote the regeneration of blood vessels in the peri-infarction region.
Keywords:astragaloside IV  enalapril  mouse  acute myocardial infarction
点击此处可从《南京医科大学学报》浏览原始摘要信息
点击此处可从《南京医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号